Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23158)

• Formulation Name: Eribulin Mesylate 1mg/2ml solution
• Company: Eisai

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Halaven	(DM7JNTV)	Breast cancer	2C60-2C65	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ethanol	(E00023)	702	Antimicrobial preservative; Penetration agent; Solvent
Water	(E00035)	962	Solvent